Evidence map›Paper›PMID 40512320›Full record

ReviewIndian journal of pediatrics2025

Resurgence of Group A Streptococcal Infections.

Winsley Rose

Abstract readReview
PubMed Publisher
In one paragraph

Review in Indian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Winsley RoseDepartment of Pediatrics, Christian Medical College, Vellore, 632004, Tamil Nadu, India. winsleyrose@cmcvellore.ac.in.ORCID 0000-0002-3496-2588

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Group A Streptococcus (GAS) causes considerable burden on the society with its varied disease manifestations than can range from asymptomatic infection to severe invasive disease which can lead to significant mortality. There was a decline in GAS infections over time with improved living conditions all over the world, however, with the COVID-19 pandemic, there has been a resurgence in the different types of GAS infections. This recent upsurge in the GAS cases worldwide and the increasing rates of antimicrobial resistance has brought the spotlight back on this organism. Many vaccines are under development, but face multiple challenges that hinder the availability of a safe and effective vaccine for widespread use.

Indexed as

Streptococcal InfectionsStreptococcus pyogenesAnti-Bacterial AgentsCOVID-19Drug Resistance, BacterialHumansSARS-CoV-2Streptococcal VaccinesAnti-Bacterial AgentsStreptococcal VaccinesGASGroup A StreptococcusStreptococcus pyogenes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.